(2S,3S,4R,5R)-5-[6-amino-2-[3-[(4-chlorobenzoyl)-cyclobutylamino]prop-1-ynyl]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide | 1556818-11-1

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘌呤核苷
• 英文名称: (2S,3S,4R,5R)-5-[6-amino-2-[3-[(4-chlorobenzoyl)-cyclobutylamino]prop-1-ynyl]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide
• CAS: 1556818-11-1
• 化学式: C₂₅H₂₆ClN₇O₅
• 分子量: 539.978
• InChiKey: SHFSYBVKHFCSHA-PBQROFAYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  38
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  169
• 氢给体数：
  4
• 氢受体数：
  9

文献信息

• N-ALKYL 2-(DISUBSTITUTED)ALKYNYLADENOSINE-5-URONAMIDES AS A2A AGONISTS
  申请人：Lewis and Clark Pharmaceuticals, Inc.

  公开号：US20170283452A9

  公开（公告）日：2017-10-05

  The present invention provides N-alkyl 2-(disubstituted)alkynyladenosine-5′-uronamides and derivatives thereof and pharmaceutical compositions containing the same that are selective agonists of A 2A adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
• US9822141B2
  申请人：——

  公开号：US9822141B2

  公开（公告）日：2017-11-21